Grandhige is the only board-certified surgeon in the Tampa Bay area who regularly performs all three techniques
Orforglipron's unrestricted oral dosing and demonstrated superiority over oral semaglutide in ACHIEVE-3 position it as the preferred oral GLP-1 option for many patients
Trelagliptin (syr-472, zafatek), novel once-weekly treatment for type 2 diabetes, inhibits dipeptidyl peptidase-4 (dpp-4) via a non-covalent mechanism
Start your weight loss consultation today
Outcome measures include frailty status using Fried criteria and Frailty Index accumulation of deficit, selected frailty biomarkers (interleukin-6, tumor necrosis factor-alpha, and insulin-like growth factor-1), physical function, cognitive function, nutritional status and biochemical profile
Standard Mounjaro Side Effects: Nausea, vomiting, diarrhoea, constipation, reduced appetite, and abdominal discomfort are common when starting or increasing doses